🇺🇸 FDA
Patent

US 9061071

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

granted A61KA61K38/1767A61K47/542

Quick answer

US patent 9061071 (Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels) held by The Regents of the University of California expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/1767, A61K47/542, A61K47/6415, A61P